HomeCompareMRRTY vs MRK

MRRTY vs MRK: Dividend Comparison 2026

MRRTY yields 28.83% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRRTY wins by $66.0K in total portfolio value
10 years
MRRTY
MRRTY
● Live price
28.83%
Share price
$3.42
Annual div
$0.99
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$123.7K
Annual income
$15,814.25
Full MRRTY calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — MRRTY vs MRK

📍 MRRTY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMRRTYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MRRTY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MRRTY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MRRTY
Annual income on $10K today (after 15% tax)
$2,450.73/yr
After 10yr DRIP, annual income (after tax)
$13,442.11/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MRRTY beats the other by $4,845.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MRRTY + MRK for your $10,000?

MRRTY: 50%MRK: 50%
100% MRK50/50100% MRRTY
Portfolio after 10yr
$90.7K
Annual income
$12,964.01/yr
Blended yield
14.29%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MRRTY
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
1.5
Piotroski
6/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MRRTY buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMRRTYMRK
Forward yield28.83%2.81%
Annual dividend / share$0.99$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$123.7K$57.7K
Annual income after 10y$15,814.25$10,113.78
Total dividends collected$83.1K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: MRRTY vs MRK ($10,000, DRIP)

YearMRRTY PortfolioMRRTY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$13,583$2,883.22$11,213$373.04+$2.4KMRRTY
2$18,194$3,660.13$12,667$512.06+$5.5KMRRTY
3$24,050$4,581.86$14,439$708.14+$9.6KMRRTY
4$31,393$5,660.23$16,640$988.16+$14.8KMRRTY
5$40,496$6,905.25$19,432$1,394.07+$21.1KMRRTY
6$51,656$8,324.76$23,057$1,992.90+$28.6KMRRTY
7$65,196$9,924.12$27,889$2,894.79+$37.3KMRRTY
8$81,465$11,706.02$34,518$4,286.29+$46.9KMRRTY
9$100,838$13,670.35$43,912$6,494.35+$56.9KMRRTY
10$123,711$15,814.25$57,714$10,113.78+$66.0KMRRTY

MRRTY vs MRK: Complete Analysis 2026

MRRTYStock

Marfrig Global Foods S.A., through its subsidiaries, operates in the food and food service industries in Brazil, the United States, Uruguay, and Argentina. It produces, processes, distributes, and sells animal-based proteins, such as beef, lamb, and fish, as well as plant-based proteins; and various other food products, including frozen vegetables, sheep, fish, and sauces. The company also engages in energy trading and associated, leasing transportation, and leather processing services. It sells and exports its products to restaurant and supermarket chains, and homes in approximately 100 countries. The company was formerly known as Marfrig Alimentos S.A. and changed its name to Marfrig Global Foods S.A. in January 2014. Marfrig Global Foods S.A. was founded in 1986 and is headquartered in São Paulo, Brazil.

Full MRRTY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MRRTY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MRRTY vs SCHDMRRTY vs JEPIMRRTY vs OMRRTY vs KOMRRTY vs MAINMRRTY vs JNJMRRTY vs ABBVMRRTY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.